Mira Pharmaceuticals

Mira Pharmaceuticals | 1,002 followers on LinkedIn. Developing the next-generation FDA-approved novel synthetic THC analog | MIRA1a is being developed to treat anxiety and cognitive decline in the elderly and neuropathic pain without impurities or the adverse side effects of cannabis plant extracts.

MIRA Pharmaceuticals, Inc. publie des données révolutionnaires issues de simulations d'intelligence artificielle -Le 04 décembre 2023 à 14:00

Tekmira to Present at the 16th Annual BIO CEO & Investor Conference

Nasdaq Exchange on X: Welcoming MIRA Pharmaceuticals to @NasdaqExchange to celebrate becoming #NasdaqListed! 🎉 $MIRA is an early-stage life sciences company focused on the development and commercialization of MIRA1a, a Novel synthetic

MIRA Pharmaceuticals, Inc. (MIRA) Stock Price, Quote & News - Stock Analysis

MIRA - candlestick chart analysis of MIRA Pharmaceuticals Inc.

MIRA Pharmaceuticals, Inc. Erez Aminov, CEO - The Wall Street Resource

in Mira Farmaceutici.

IPO Update: Mira Pharmaceuticals Aims For Mini-IPO (Pending:MIRA)

Erez Aminov - Chief Executive Officer at Mira Pharmaceuticals, Inc.